GlassScriptPhysician profile
Susan Majlessi
NPI 1639205826
$4,030.95
in general payments reported to CMS, 2019-2025
19 companies · $349 in 2025
The $349 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,753 · 2020: $42.32 · 2021: $124 · 2022: $301 · 2023: $823 · 2024: $638 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,810.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,810.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $1,718.39 | 2019 | |
| Sun Pharmaceutical Industries INC. | $456.77 | 2021-2025 | Cequa |
| Lumenis Be INC | $381.78 | 2023 | Optilight |
| Abbvie INC. | $310.27 | 2022-2024 | |
| Tarsus Pharmaceuticals, INC. | $267.03 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $216.02 | 2020-2025 | Argos, Rocklatan, Tryptyr |
| Bausch & Lomb Americas INC. | $176.50 | 2023-2025 | Xiidra, Miebo |
| Oyster Point Pharma, INC. | $146.13 | 2022-2024 | Tyrvaya, Ryzumvi |
| Novartis Pharmaceuticals Corporation | $75.29 | 2023 | |
| Kala Pharmaceuticals, INC. | $57.07 | 2021 | |
| Rxsight INC | $55.10 | 2022 | |
| Allergan, INC. | $51.06 | 2020-2022 | |
| Carl Zeiss Meditec USA, INC. | $22.78 | 2025 | Cirrus Hd-Oct |
| Shire North American Group INC | $21.66 | 2019 | |
| Oasis Medical, INC. | $18.33 | 2024 | Oasis Tears |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harrow Eye, LLC | $16.61 | 2025 | Vevye |
| Omeros Corporation | $14.50 | 2021 | |
| Eyevance Pharmaceuticals LLC | $13.00 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $12.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Majlessi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.